03:56 PM EDT, 03/26/2026 (MT Newswires) -- Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index decreasing 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) down 0.2%.

The iShares Biotechnology ETF (IBB) eased 0.1%.

In corporate news, ADMA Biologics ( ADMA ) shares fell past 15% after Cantor Fitzgerald downgraded the stock to neutral from overweight.

Boston Scientific's ( BSX ) CHAMPION-AF trial of its heart implant device to lower stroke risk is among the most anticipated study readouts this year, Oppenheimer said in a note Thursday. Boston Scientific ( BSX ) shares added 0.8%.

Kodiak Sciences ( KOD ) shares surged 73% after the firm said Thursday that topline data from a phase 3 trial of tarcocimab tedromer showed superiority over sham in people with diabetic retinopathy, meeting its primary endpoint.